Down 10% in a day! Why this ASX stock could now deliver market-beating returns

On Thursday, Neuren Pharmaceuticals Ltd (ASX: NEU) shares were sold off and finished the day 10% lower.

While this is disappointing for shareholders, the team at Bell Potter thinks that it has created an attractive entry point for investors.

What is the broker saying?

…